Reference health

Virtual hypoxia and chronic necrosis of demyelinated axons in multiple sclerosis

https://doi.org/10.1016/s1474-4422(09)70043-2
CiteStamped reference-health badge
103/103 checkable references clean · checked 2026-07-23

Every reference with a DOI in the deposited reference list resolved to a known work in Crossref or DataCite at the dated check, and none carried a retraction, withdrawal, or removal notice.

5 without a DOI — not checked. A reference deposited without a DOI is never matched by title or guessed at; it stays outside the checked set, and this line discloses that.

The 103 checked references that resolve
resolves10.1056/NEJM200009283431307
Multiple Sclerosis
resolves10.1016/S0733-8619(05)70257-7
EPIDEMIOLOGY OF MULTIPLE SCLEROSIS
resolves10.1146/annurev.neuro.30.051606.094313
Multiple Sclerosis: An Immune or Neurodegenerative Disorder?
resolves10.1007/s12015-008-9043-z
Paving the Axonal Highway: From Stem Cells to Myelin Repair
resolves10.1111/j.1750-3639.1999.tb00547.x
Axonal Pathology in Multiple Sclerosis. A Historical Note
resolves10.1056/NEJM199801293380502
Axonal Transection in the Lesions of Multiple Sclerosis
resolves10.1046/j.1365-2990.1999.00205.x
Spinal cord axonal loss in multiple sclerosis: a <i>post‐mortem</i><b> study</b>
resolves10.1093/brain/123.2.308
Axonal changes in chronic demyelinated cervical spinal cord plaques
resolves10.1212/WNL.57.7.1248
Axonal loss in normal-appearing white matter in a patient with acute MS
resolves10.1212/WNL.53.8.1698
Use of the brain parenchymal fraction to measure whole brain atrophy in relapsing-remitting MS
resolves10.1212/WNL.53.1.139
A longitudinal study of brain atrophy in relapsing multiple sclerosis
resolves10.1002/ana.410360115
Use of proton magnetic resonance spectroscopy for monitoring disease progression in multiple sclerosis
resolves10.1093/brain/119.3.715
Assessment of lesion pathology in multiple sclerosis using quantitative MRI morphometry and magnetic resonance spectroscopy
resolves10.1002/1531-8249(200012)48:6<893::AID-ANA10>3.0.CO;2-B
Neurological disability correlates with spinal cord axonal loss and reducedN-acetyl aspartate in chronic multiple sclerosis patients
resolves10.1126/science.280.5369.1610
Axonal Swellings and Degeneration in Mice Lacking the Major Proteolipid of Myelin
resolves10.1038/ng1095
Disruption of Cnp1 uncouples oligodendroglial functions in axonal support and myelination
resolves10.1523/JNEUROSCI.18-06-01953.1998
Myelin-Associated Glycoprotein Is a Myelin Signal that Modulates the Caliber of Myelinated Axons
resolves10.1097/00019052-199906000-00008
Axonal pathology in multiple sclerosis: relationship to neurologic disability
resolves10.1177/107385849900500107
Neurodegeneration in Multiple Sclerosis: Relationship to Neurological Disability
resolves10.1023/A:1007010205037
Axonal pathology in myelin disorders
resolves10.1093/brain/123.11.2314
Evidence for adaptive functional changes in the cerebral cortex with axonal injury from multiple sclerosis
resolves10.1016/S1053-8119(03)00043-0
Evidence for axonal pathology and adaptive cortical reorganization in patients at presentation with clinically isolated syndromes suggestive of multiple sclerosis
resolves10.1093/brain/awf164
Cortical motor reorganization after a single clinical attack of multiple sclerosis
resolves10.1093/brain/awg284
Potentially adaptive functional changes in cognitive processing for patients with multiple sclerosis and their acute modulation by rivastigmine
resolves10.1146/annurev.neuro.30.051606.094309
Axon-Glial Signaling and the Glial Support of Axon Function
resolves10.1016/S0002-9440(10)64537-3
Multiple Sclerosis and Chronic Autoimmune Encephalomyelitis
resolves10.1016/S1474-4422(02)00102-3
The role of nitric oxide in multiple sclerosis
resolves10.1016/j.jns.2005.03.003
Sodium-mediated axonal degeneration in inflammatory demyelinating disease
resolves10.1002/ana.20736
Mitochondrial dysfunction as a cause of axonal degeneration in multiple sclerosis patients
resolves10.1093/brain/awn105
Mitochondrial defects in acute multiple sclerosis lesions
resolves10.1073/pnas.0402765101
Molecular changes in neurons in multiple sclerosis: Altered axonal expression of Na <sub>v</sub> 1.2 and Na <sub>v</sub> 1.6 sodium channels and Na <sup>+</sup> /Ca <sup>2</sup> + exchanger
resolves10.1002/ana.20082
Axonal degeneration in multiple sclerosis: Is it time for neuroprotective strategies?
resolves10.1002/ana.21381
Imaging correlates of decreased axonal Na <sup>+</sup> /K <sup>+</sup> ATPase in chronic multiple sclerosis lesions
resolves10.1097/nen.0b013e3181462841
Sodium Channel Expression Within Chronic Multiple Sclerosis Plaques
resolves10.1046/j.1471-4159.1997.68051920.x
Intracellular Concentrations of Major Ions in Rat Myelinated Axons and Glia: Calculations Based on Electron Probe X‐Ray Microanalyses
resolves10.1016/j.neuron.2003.08.016
Depolarization-Induced Ca2+ Release in Ischemic Spinal Cord White Matter Involves L-type Ca2+ Channel Activation of Ryanodine Receptors
resolves10.1152/jn.1995.74.1.369
Voltage-gated calcium channels in CNS white matter: role in anoxic injury
resolves10.1113/jphysiol.2006.116798
Complex interplay between glutamate receptors and intracellular Ca<sup>2+</sup> stores during ischaemia in rat spinal cord white matter
resolves10.1093/brain/120.3.393
Axonal damage in acute multiple sclerosis lesions
resolves10.1523/JNEUROSCI.16-16-05095.1996
Oligodendroglia Regulate the Regional Expansion of Axon Caliber and Local Accumulation of Neurofilaments during Development Independently of Myelin Formation
resolves10.1016/S0169-328X(97)00117-4
Protein serine/threonine phosphatase 1 and 2A associate with and dephosphorylate neurofilaments
resolves10.1093/brain/124.6.1114
Distribution of a calcium channel subunit in dystrophic axons in multiple sclerosis and experimental autoimmune encephalomyelitis
resolves10.1093/brain/123.6.1174
Acute axonal injury in multiple sclerosis: Correlation with demyelination and inflammation
resolves10.1016/S0304-3940(02)00469-X
Calpain-dependent neurofilament breakdown in anoxic and ischemic rat central axons
resolves10.1073/pnas.96.20.11486
A putative mechanism of demyelination in multiple sclerosis by a proteolytic enzyme, calpain
resolves10.1089/neu.1995.12.555
The Pathobiology of Traumatically Induced Axonal Injury in Animals and Humans: A Review of Current Thoughts
resolves10.1089/neu.1998.15.441
Axonal Injury Caused by Focal Cerebral Ischemia in the Rat
resolves10.1111/j.1750-3639.2007.00066.x
Sodium Channels and Multiple Sclerosis: Roles in Symptom Production, Damage and Therapy
resolves10.1073/pnas.90.15.6976
Noninactivating, tetrodotoxin-sensitive Na+ conductance in rat optic nerve axons.
resolves10.1016/0166-2236(93)90077-Y
Na+ currents that fail to inactivate
resolves10.1002/ana.410360515
Induction of nitric oxide synthase in demyelinating regions of multiple sclerosis brains
resolves10.1152/physrev.00029.2006
Nitric Oxide and Peroxynitrite in Health and Disease
resolves10.1093/brain/120.12.2149
Nitric oxide donors reversibly block axonal conduction: demyelinated axons are especially susceptible
resolves10.1002/ana.96
Electrically active axons degenerate when exposed to nitric oxide
resolves10.1002/ana.10443
Blockers of sodium and calcium entry protect axons from nitric oxide‐mediated degeneration
resolves10.1016/j.molmed.2006.03.001
Ions, energy and axonal injury: towards a molecular neurology of multiple sclerosis
resolves10.1056/NEJM199403033300907
Excitatory Amino Acids as a Final Common Pathway for Neurologic Disorders
resolves10.1016/S0166-2236(00)01746-X
The link between excitotoxic oligodendroglial death and demyelinating diseases
resolves10.1038/ni0901-762
Multiple sclerosis: a two-stage disease
resolves10.1016/S0022-510X(02)00421-5
Hypoxia-like tissue injury as a component of multiple sclerosis lesions
resolves10.1523/JNEUROSCI.23-09-03588.2003
Functional Hemichannels in Astrocytes: A Novel Mechanism of Glutamate Release
resolves10.1016/j.neuint.2003.12.011
Mechanisms of glutamate release from astrocytes: gap junction “hemichannels”, purinergic receptors and exocytotic release
resolves10.1038/nn1854
Vesicular release of glutamate from unmyelinated axons in white matter
resolves10.1523/JNEUROSCI.19-14-j0002.1999
Novel Injury Mechanism in Anoxia and Trauma of Spinal Cord White Matter: Glutamate Release via Reverse Na<sup>+</sup>-dependent Glutamate Transport
resolves10.1038/sj.jcbfm.9600455
Excitotoxic Mechanisms of Ischemic Injury in Myelinated White Matter
resolves10.1038/nature04302
NMDA receptors are expressed in oligodendrocytes and activated in ischaemia
resolves10.1038/nature04301
NMDA receptors are expressed in developing oligodendrocyte processes and mediate injury
resolves10.1038/nature04474
NMDA receptors mediate calcium accumulation in myelin during chemical ischaemia
resolves10.1093/brain/awh467
Evidence of elevated glutamate in multiple sclerosis using magnetic resonance spectroscopy at 3 T
resolves10.1016/j.neuroimage.2005.10.048
TE-Averaged two-dimensional proton spectroscopic imaging of glutamate at 3 T
resolves10.1002/glia.20275
Glutamate‐mediated glial injury: Mechanisms and clinical importance
resolves10.1093/brain/awh302
Resistance of human adult oligodendrocytes to AMPA/kainate receptor-mediated glutamate injury
resolves10.1523/JNEUROSCI.21-12-04237.2001
AMPA/Kainate Receptor Activation Mediates Hypoxic Oligodendrocyte Death and Axonal Injury in Cerebral White Matter
resolves10.1523/JNEUROSCI.20-03-01190.2000
Mechanisms of Ionotropic Glutamate Receptor-Mediated Excitotoxicity in Isolated Spinal Cord White Matter
resolves10.1038/71555
Glutamate excitotoxicity in a model of multiple sclerosis
resolves10.1038/71548
Autoimmune encephalomyelitis ameliorated by AMPA antagonists
resolves10.1111/j.1749-6632.2003.tb07533.x
Multiple Sclerosis and Glutamate
resolves10.1111/j.1471-4159.2006.03991.x
The chemical biology of clinically tolerated NMDA receptor antagonists
resolves10.1016/0022-510X(95)00339-4
Memantine abrogates neurological deficits, but not CNS inflammation, in Lewis rat experimental autoimmune encephalomyelitis
resolves10.1002/ana.21436
Gray matter atrophy in multiple sclerosis: A longitudinal study
resolves10.1002/ana.21423
Gray matter atrophy is related to long‐term disability in multiple sclerosis
resolves10.1002/ana.21113
Imaging correlates of axonal swelling in chronic multiple sclerosis brains
resolves10.1002/ana.21311
Homogeneity of active demyelinating lesions in established multiple sclerosis
resolves10.1097/00019052-200206000-00022
Anti-inflammatory strategies to prevent axonal injury in multiple sclerosis
resolves10.1097/01.wco.0000236612.66839.a2
Multiple sclerosis, natalizumab therapy, and progressive multifocal leukoencephalopathy
resolves10.1016/S0166-2236(99)01405-8
Innate and adaptive immune responses can be beneficial for CNS repair
resolves10.1007/s00415-005-0934-5
The window of therapeutic opportunity in multiple sclerosis
resolves10.1093/brain/awl370
Autologous haematopoietic stem cell transplantation fails to stop demyelination and neurodegeneration in multiple sclerosis
resolves10.1523/JNEUROSCI.18-16-06093.1998
Functional Analysis of the Mouse Scn8a Sodium Channel
resolves10.1073/pnas.93.17.9270
Common molecular determinants of local anesthetic, antiarrhythmic, and anticonvulsant block of voltage-gated Na+ channels.
resolves10.1152/jn.1992.67.1.236
Tertiary and quaternary local anesthetics protect CNS white matter from anoxic injury at concentrations that do not block excitability
resolves10.1038/nm1568
Real-time measurement of free Ca2+ changes in CNS myelin by two-photon microscopy
resolves10.1002/ana.20045
Axonal protection using flecainide in experimental autoimmune encephalomyelitis
resolves10.1152/jn.00434.2003
Phenytoin Protects Spinal Cord Axons and Preserves Axonal Conduction and Neurological Function in a Model of Neuroinflammation In Vivo
resolves10.1002/ana.21172
Exacerbation of experimental autoimmune encephalomyelitis after withdrawal of phenytoin and carbamazepine
resolves10.1007/s00415-006-0204-1
Axonal protection achieved in a model of multiple sclerosis using lamotrigine
resolves10.1002/(SICI)1098-1136(199705)20:1<79::AID-GLIA8>3.0.CO;2-0
Glutamate metabolism is down-regulated in astrocytes during experimental allergic encephalomyelitis
resolves10.1002/ana.1077
Multiple sclerosis: Altered glutamate homeostasis in lesions correlates with oligodendrocyte and axonal damage
resolves10.1523/JNEUROSCI.17-03-01055.1997
Role of NMDA and Non-NMDA Ionotropic Glutamate Receptors in Traumatic Spinal Cord Axonal Injury
resolves10.1006/exnr.1997.6506
Delayed Antagonism of AMPA/Kainate Receptors Reduces Long-Term Functional Deficits Resulting from Spinal Cord Trauma
resolves10.1016/j.brainres.2008.07.124
Prevention of axonal injury using calpain inhibitor in chronic progressive experimental autoimmune encephalomyelitis
resolves10.1046/j.1471-4159.2000.0742101.x
Calpain Inhibitors Confer Biochemical, but Not Electrophysiological, Protection Against Anoxia in Rat Optic Nerves
resolves10.1523/JNEUROSCI.4017-06.2007
Passive Immunization with Anti-Ganglioside Antibodies Directly Inhibits Axon Regeneration in an Animal Model
The 5 references without a DOI — listed, not checked
no DOI — not checked10.1016/S1474-4422(09)70043-2_bib3
no DOI — not checkedOuardouz M, Coderre E, Basak A, et al. Glutamate receptors on myelinated spinal cord axons: I) GluR6 kainate receptors. Ann Neurol (in press).
no DOI — not checkedOuardouz M, Coderre E, Zamponi GW, et al. Glutamate receptors on myelinated spinal cord axons: II) AMPA and GluR5 receptors. Ann Neurol (in press).
no DOI — not checkedMultiple sclerosis: therapy
no DOI — not checkedLoss of Na+ channel β2 subunits is neuroprotective in a mouse model of multiple sclerosis
What this badge says. CiteStamped means the CHECKABLE references of this work were clean at the dated check: each resolved to a known work in a public registry, and none carried a retraction notice at that time. It says nothing about the quality, findings, or importance of the work itself, and nothing about references deposited without a DOI.

checked 2026-07-23 — re-checked daily as this page is visited; titles and statuses come from Crossref and DataCite and are not part of the signed record

Embed this badge

Both snippets point at the live badge image and link back to this page. The badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.

<a href="https://citestamp.com/citestamped/10.1016/s1474-4422(09)70043-2"><img src="https://citestamp.com/citestamped/10.1016/s1474-4422(09)70043-2/badge.svg" alt="CiteStamped reference-health badge" width="460" height="64"></a>
[![CiteStamped reference-health badge](https://citestamp.com/citestamped/10.1016/s1474-4422(09)70043-2/badge.svg)](https://citestamp.com/citestamped/10.1016/s1474-4422(09)70043-2)